The gut microbiome influences drug metabolism, absorption, and efficacy. Intestinal organoids enable study of host-microbe interactions, drug absorption, and IBD in human tissue with proper epithelial architecture.
ABSORPTION
Intestinal Permeability
Gut organoids assess oral drug absorption with human-relevant Papp values for bioavailability prediction.
IBD
Disease Modeling
Patient-derived organoids model Crohn's and ulcerative colitis for personalized treatment selection.